BR112012000530A2 - uso de uma população de nanopartículas metálicas, e, composição farmacêutica. - Google Patents

uso de uma população de nanopartículas metálicas, e, composição farmacêutica.

Info

Publication number
BR112012000530A2
BR112012000530A2 BR112012000530A BR112012000530A BR112012000530A2 BR 112012000530 A2 BR112012000530 A2 BR 112012000530A2 BR 112012000530 A BR112012000530 A BR 112012000530A BR 112012000530 A BR112012000530 A BR 112012000530A BR 112012000530 A2 BR112012000530 A2 BR 112012000530A2
Authority
BR
Brazil
Prior art keywords
population
pharmaceutical composition
metallic nanoparticles
nanoparticles
metallic
Prior art date
Application number
BR112012000530A
Other languages
English (en)
Other versions
BR112012000530A8 (pt
BR112012000530B1 (pt
BR112012000530B8 (pt
Inventor
Agnés Pottier
Laurence Maggiorella
Laurence Poul
Laurent Levy
Original Assignee
Nanobiotix
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanobiotix filed Critical Nanobiotix
Priority to BR122019025997A priority Critical patent/BR122019025997B8/pt
Publication of BR112012000530A2 publication Critical patent/BR112012000530A2/pt
Publication of BR112012000530A8 publication Critical patent/BR112012000530A8/pt
Publication of BR112012000530B1 publication Critical patent/BR112012000530B1/pt
Publication of BR112012000530B8 publication Critical patent/BR112012000530B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092Details
    • A61N2005/1098Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112012000530A 2009-07-10 2010-07-09 uso de uma população de nanopartículas de ouro, e, composição farmacêutica BR112012000530B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR122019025997A BR122019025997B8 (pt) 2009-07-10 2010-07-09 uso de uma população de nanopartículas metálicas

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22457609P 2009-07-10 2009-07-10
EP09165157A EP2275137A1 (en) 2009-07-10 2009-07-10 Metallic nanoparticles, preparation and uses thereof
EP09165157.0 2009-07-10
US61/224,576 2009-07-10
PCT/EP2010/059871 WO2011003999A1 (en) 2009-07-10 2010-07-09 Metallic nanoparticles, preparation and uses thereof

Publications (4)

Publication Number Publication Date
BR112012000530A2 true BR112012000530A2 (pt) 2016-11-16
BR112012000530A8 BR112012000530A8 (pt) 2017-12-26
BR112012000530B1 BR112012000530B1 (pt) 2021-01-19
BR112012000530B8 BR112012000530B8 (pt) 2021-05-25

Family

ID=41110399

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112012000530A BR112012000530B8 (pt) 2009-07-10 2010-07-09 uso de uma população de nanopartículas de ouro, e, composição farmacêutica
BR122019025997A BR122019025997B8 (pt) 2009-07-10 2010-07-09 uso de uma população de nanopartículas metálicas

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR122019025997A BR122019025997B8 (pt) 2009-07-10 2010-07-09 uso de uma população de nanopartículas metálicas

Country Status (25)

Country Link
US (2) US9700621B2 (pt)
EP (3) EP2275137A1 (pt)
JP (1) JP5739883B2 (pt)
KR (1) KR101670757B1 (pt)
CN (1) CN102470173B (pt)
AU (1) AU2010270225B2 (pt)
BR (2) BR112012000530B8 (pt)
CA (1) CA2765290C (pt)
CY (1) CY1118600T1 (pt)
DK (2) DK3178494T3 (pt)
EA (1) EA020942B1 (pt)
ES (2) ES2837412T3 (pt)
HR (2) HRP20170175T1 (pt)
HU (2) HUE031796T2 (pt)
IL (1) IL217287A (pt)
LT (1) LT2451481T (pt)
MA (1) MA33516B1 (pt)
MX (2) MX347606B (pt)
NZ (1) NZ597564A (pt)
PL (2) PL2451481T3 (pt)
PT (2) PT3178494T (pt)
SG (2) SG177611A1 (pt)
SI (1) SI2451481T1 (pt)
WO (1) WO2011003999A1 (pt)
ZA (1) ZA201200902B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102051248B1 (ko) 2009-07-08 2019-12-02 클레네 나노메디슨, 인크. 의학적 치료를 위한 신규한 금계 나노결정 및 이를 위한 전기화학 제조 방법
EP2275137A1 (en) * 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof
US20120190979A1 (en) 2011-01-24 2012-07-26 Actium BioSystems, LLC System for automatically amending energy field characteristics in the application of an energy field to a living organism for treatment of invasive agents
KR102069907B1 (ko) * 2011-08-26 2020-01-23 엔도마그네틱스 엘티디 체강 및 공동형 부위에 있는 암을 치료하기 위한 에너지 필드 발생 장치
AU2012351537B2 (en) 2011-12-16 2017-03-02 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
US10098952B2 (en) * 2013-01-25 2018-10-16 Nanobiotix Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer
JP6387400B2 (ja) * 2013-05-30 2018-09-05 ナノビオティックスNanobiotix 医薬組成物、その製造および使用
WO2014202723A1 (en) * 2013-06-20 2014-12-24 Nanobiotix Compositions and methods for use in medical diagnosis
TWI689310B (zh) 2014-07-11 2020-04-01 巨生生醫股份有限公司 治療鐵缺乏症之方法
JP6778371B2 (ja) * 2015-01-23 2020-11-04 ミヨシ油脂株式会社 金微粒子マトリックスメタロプロテアーゼ阻害剤
WO2016189125A1 (en) 2015-05-28 2016-12-01 Nanobiotix Nanoparticles for use as a therapeutic vaccine
DE102017101057A1 (de) * 2017-01-20 2018-07-26 Fraunhofer-Institut für Angewandte Polymerforschung IAP Zwitterionische Nanopartikel
JP7376901B2 (ja) * 2017-11-13 2023-11-09 国立大学法人北海道大学 修飾金属ナノ粒子及び医薬組成物
CN110883341B (zh) * 2018-09-11 2021-03-30 清华大学 金纳米团簇制备方法
WO2021060498A1 (ja) * 2019-09-27 2021-04-01 国立大学法人京都大学 多孔性シリカを含むナノ粒子およびその製造方法、ならびに放射線治療用医薬組成物
EP4157457A1 (en) * 2020-05-26 2023-04-05 Nanobiotix Nanoparticles, ionizing radiation and innovative therapeutic combinations thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006244A2 (en) * 1998-07-30 2000-02-10 Hainfeld James F Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
US20070031337A1 (en) * 2004-06-22 2007-02-08 Reinhard Schulte Nanoparticle enhanced proton computed tomography and proton therapy
DE102007040934A1 (de) 2007-08-30 2009-03-05 Man Diesel A/S Verfahren und Vorrichtung zur Reinigung von Abgas
EP2130553A1 (en) * 2008-06-05 2009-12-09 Nanobiotix Inorganic nanoparticles of high density to destroy cells in-vivo
EP2275137A1 (en) * 2009-07-10 2011-01-19 Nanobiotix Metallic nanoparticles, preparation and uses thereof

Also Published As

Publication number Publication date
US20120203050A1 (en) 2012-08-09
KR20120052979A (ko) 2012-05-24
US10391174B2 (en) 2019-08-27
CY1118600T1 (el) 2017-07-12
BR122019025997B8 (pt) 2021-07-27
MA33516B1 (fr) 2012-08-01
BR122019025997B1 (pt) 2020-11-24
DK2451481T3 (en) 2017-03-06
US9700621B2 (en) 2017-07-11
SG10201403832YA (en) 2014-09-26
PT3178494T (pt) 2020-12-21
EP2451481B1 (en) 2017-01-25
BR112012000530A8 (pt) 2017-12-26
CA2765290C (en) 2018-02-13
US20170296661A1 (en) 2017-10-19
EA020942B1 (ru) 2015-02-27
MX347606B (es) 2017-05-04
HRP20202005T1 (hr) 2021-02-19
SG177611A1 (en) 2012-02-28
EP2451481A1 (en) 2012-05-16
PL2451481T3 (pl) 2017-07-31
IL217287A (en) 2016-05-31
HRP20170175T1 (hr) 2017-06-02
HUE052686T2 (hu) 2021-05-28
BR112012000530B1 (pt) 2021-01-19
BR112012000530B8 (pt) 2021-05-25
CN102470173B (zh) 2015-04-22
AU2010270225B2 (en) 2014-08-28
CA2765290A1 (en) 2011-01-13
NZ597564A (en) 2013-06-28
ES2837412T3 (es) 2021-06-30
WO2011003999A1 (en) 2011-01-13
LT2451481T (lt) 2017-05-25
EP3178494B1 (en) 2020-10-14
CN102470173A (zh) 2012-05-23
EP2275137A1 (en) 2011-01-19
PT2451481T (pt) 2017-03-06
AU2010270225A1 (en) 2012-01-19
HUE031796T2 (en) 2017-08-28
ZA201200902B (en) 2012-10-31
PL3178494T3 (pl) 2021-04-06
KR101670757B1 (ko) 2016-10-31
EP3178494A1 (en) 2017-06-14
IL217287A0 (en) 2012-02-29
MX2012000285A (es) 2012-02-08
SI2451481T1 (sl) 2017-04-26
JP2012532847A (ja) 2012-12-20
EA201270154A1 (ru) 2012-07-30
JP5739883B2 (ja) 2015-06-24
DK3178494T3 (da) 2020-12-21
ES2616628T3 (es) 2017-06-13

Similar Documents

Publication Publication Date Title
BR112012000530A8 (pt) uso de uma população de nanopartículas metálicas, e, composição farmacêutica.
BRPI1010768A2 (pt) composto, e, composição farmacêutica.
BRPI1007018A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI1008906A2 (pt) composto, composição farmacêutica, e, uso de um composto.
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
BRPI1014316A2 (pt) composição, e, uso de uma composição
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BR112013003536A2 (pt) composição, e utilização de uma composição.
BRPI1009372A2 (pt) compostos, composição farmacêutica e respectivos usos
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
IT1403847B1 (it) Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BRPI1009757A2 (pt) composto, composição farmacêutica, e , uso de um composto.
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BRPI1016194A2 (pt) Composição inseticida que compreende uma espinosina e um óxido de metal.
BRPI1012250A2 (pt) composição lubrificante, e, uso de uma composição lubrificante

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2730 DE 02-05-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.